Figure 1: GDF11 treatment leads to bone loss in young adult mice. | Nature Communications

Figure 1: GDF11 treatment leads to bone loss in young adult mice.

From: GDF11 decreases bone mass by stimulating osteoclastogenesis and inhibiting osteoblast differentiation

Figure 1

(a) Representative images of microCT reconstruction of distal femurs. Scale bar, 500 μm. (b) Von Kossa staining of undecalicified sections of femurs. Scale bar, 500 μm. (c) TRAP staining of femur sections from vehicle and rGDF11 treated mice. Scale bar, 50 μm. (d) Histomorphometric analysis of the metaphysis region of distal femurs. Results are shown as mean±s.d.; n=6–10; *P<0.05, **P<0.01 and ***P<0.001 by analysis of variance (ANOVA) with Tukey’s post hoc test. (e,f) The serum levels of CTX and P1NP. Results are shown as mean±s.d.; n=6–10; *P<0.05 by ANOVA with Tukey’s post hoc test.

Back to article page